Protagenic Therapeutics, Inc.\new Deferred Income Tax Expense (Benefit)
Protagenic Therapeutics, Inc.\new (PTIX) reported Deferred Income Tax Expense (Benefit) of $37.00 thousand for the 9-month period ending 2010-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2011-11-14
- Protagenic Therapeutics, Inc.\new deferred income tax expense (benefit) for the quarter ending 2010-09-30 was $16.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month |
|---|---|---|---|
| 2010-09-30 | $16.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $37.00K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $21.00K 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |